TPCW
AVNS

TD Private Client Wealth’s Avanos Medical AVNS Stock Holding History

TD Private Client Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182 Hold
13
– – ﹤0.01% 1582
2025
Q4 		$146 Buy
+13
New +$149 ﹤0.01% 1575

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

TD Private Client Wealth's AVNS Position: Q1 2026 in Review

TD Private Client Wealth held its Avanos Medical (AVNS) position steady in Q1 2026 at 13 shares worth $182. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

TD Private Client Wealth first reported a position in AVNS in Q4 2025 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • TD Private Client Wealth held 13 shares of Avanos Medical worth $182 as of Q1 2026.
  • TD Private Client Wealth left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #1582 holding.
  • TD Private Client Wealth first reported a position in Avanos Medical in Q4 2025 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.